Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2018 08:05 ET | Source: Novan, Inc.

Novan to Participate in Upcoming Investor Conferences

MORRISVILLE, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that members of management are scheduled to attend the 2018 Cantor...
June 01, 2018 08:05 ET | Source: Novan, Inc.

Novan Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today reported that the Compensation Committee of Novan’s Board of Directors granted stock...
May 17, 2018 08:05 ET | Source: Novan, Inc.

SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment

MORRISVILLE, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that data from the Company’s onychomycosis development program with SB208 gel...
May 15, 2018 08:10 ET | Source: Novan, Inc.

Novan Provides Update on SB414 Inflammatory Skin Disease Development Program

SB414 – Nitric Oxide-Releasing Cream – Safe and Well-Tolerated in Psoriasis Phase 1b Trial Preclinical Data with SB414 Targeting Key Inflammatory Cytokines IL-4 and IL-13 in Atopic Dermatitis to be...
April 12, 2018 07:05 ET | Source: Novan, Inc.

Novan Advances Organization and Strengthens Leadership Team

CEO Role No Longer “Interim”Clinical Operations Role Established Finance Team Positioned for the Future MORRISVILLE, N.C., April 12, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or...
March 29, 2018 08:05 ET | Source: Novan, Inc.

Novan Announces Corporate Update Conference Call and Webcast

MORRISVILLE, N.C., March 29, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Thursday, April 12, at 8:30...
February 21, 2018 08:00 ET | Source: Novan, Inc.

Dr. Eugene Sun Appointed to Novan Board of Directors

Complements existing Board expertise as 30-year clinician, drug developer and former biopharmaceutical CEOWill provide expert perspective on the clinical application of the underlying nitric oxide...
February 13, 2018 08:05 ET | Source: Novan, Inc.

Novan to Present Integrated Data from Phase 3 Trials with SB204 for Treatment of Acne

MORRISVILLE, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that data from the Company’s two Phase 3 clinical trials and long-term...
January 25, 2018 09:00 ET | Source: Novan, Inc.

Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206

MORRISVILLE, N.C., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that the first patient has been dosed in the Company's Phase 2 clinical...
January 11, 2018 09:15 ET | Source: Novan, Inc.

Novan Announces Closing of Offering of Common Stock and Warrants

MORRISVILLE, N.C., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (the “Company" or "Novan") (NASDAQ:NOVN) today announced that it has closed its previously announced underwritten public offering. ...